These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 1379701

  • 1. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 2. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY, Luthy DA, Zebelman AM, Williams MA, Lieppman RE, Hickok DE.
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
    Mooney RA, Peterson CJ, French CA, Saller DN, Arvan DA.
    Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
    [Abstract] [Full Text] [Related]

  • 5. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML, Wagner RM, Slotnick RN.
    Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
    [Abstract] [Full Text] [Related]

  • 6. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
    Dick PT.
    CMAJ; 1996 Feb 15; 154(4):465-79. PubMed ID: 8630836
    [Abstract] [Full Text] [Related]

  • 7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr 15; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 8. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
    Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A.
    Obstet Gynecol; 1993 May 15; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
    Heyl PS, Miller W, Canick JA.
    Obstet Gynecol; 1990 Dec 15; 76(6):1025-31. PubMed ID: 1700348
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA.
    N Engl J Med; 1994 Apr 21; 330(16):1114-8. PubMed ID: 7510852
    [Abstract] [Full Text] [Related]

  • 14. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A.
    Prenat Diagn; 1997 Sep 21; 17(9):861-6. PubMed ID: 9316131
    [Abstract] [Full Text] [Related]

  • 15. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA, Ying J, Beazoglou T, Egan JF.
    Prenat Diagn; 2001 Jan 21; 21(1):46-51. PubMed ID: 11180240
    [Abstract] [Full Text] [Related]

  • 16. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME, First and Second Trimester Evaluation of Risk (FASTER) Research Consortium.
    Obstet Gynecol; 2007 Sep 21; 110(3):651-7. PubMed ID: 17766613
    [Abstract] [Full Text] [Related]

  • 17. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2007 Oct 21; 90(10):1970-6. PubMed ID: 18041410
    [Abstract] [Full Text] [Related]

  • 18. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
    Rice JD, McIntosh SF, Halstead AC.
    Prenat Diagn; 2005 Mar 21; 25(3):234-8. PubMed ID: 15791658
    [Abstract] [Full Text] [Related]

  • 19. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
    Craig WY, Haddow JE, Palomaki GE, Roberson M.
    Prenat Diagn; 2007 May 21; 27(5):409-14. PubMed ID: 17286308
    [Abstract] [Full Text] [Related]

  • 20. [Evaluation of trisomy 21 risk by serial determination of chorionic gonadotrophin hormone and alpha-fetoprotein: results of a national pilot study].
    Aymé S, Aurran Y, Chabal F, Gombert A, Loundou H, Montfort C, Sollier M, Silvestri A.
    Contracept Fertil Sex; 1993 Feb 21; 21(2):133-43. PubMed ID: 7524931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.